News BIO Announces Appointment of Rachel King as Interim CEO | Business Wire WASHINGTON--(BUSINESS WIRE)--The Biotechnology Innovation Organization (BIO) – the world’s largest science and public advocacy organization,…Super UserOctober 11, 2022
News Neuroene Therapeutics Wins 7th Annual BioHealth Capital Region Crab Trap Competition Neuroene and Polaris Genomics benefit from increased prizes Did you miss the 7th Annual BioHealth…Super UserOctober 11, 2022
News University of Maryland, Baltimore and Wexford Meeting Critical Demand for Wet Lab Space in Baltimore Region Doubling the University of Maryland BioPark’s lab space, the two-phase 4MLK development project will represent…Super UserOctober 10, 2022
News Adaptive Phage Therapeutics Awarded Additional $5 Million from U.S. Defense Health Agency to Support Diabetic Foot Osteomyelitis Clinical Trial | Business Wire GAITHERSBURG, Md--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company advancing the world’s largest…Super UserOctober 10, 2022
News NexImmune Announces Research Collaboration with National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) The collaboration will explore EBV and HTLV-1 antigen-specific immune responses in immunological diseases GAITHERSBURG, Md.,…Super UserOctober 10, 2022
News Congress reauthorizes the SBIR/STTR Programs | SBIR.gov WASHINGTON – Administrator Isabella Casillas Guzman, head of the U.S. Small Business Administration and voice…Super UserOctober 10, 2022
News Industry Leaders Share Optimism on the Region’s Life Sciences Economic Outlook Amid Recession Concerns · BioBuzz It’s no secret that a recession could hit the United States before the year ends.…Super UserOctober 10, 2022
News 51 “Build to Scale” Grants Totaling $47 Million Awarded to Fuel Innovation and Tech-Based Economic Development Today, the U.S. Economic Development Administration awarded 51 “Build to Scale” grants – totaling $47…Super UserOctober 10, 2022
News Richmond Times-Dispatch: Inside greater Richmond’s big plan for pharmaceutical manufacturing The Richmond area is planning a major pharmaceutical manufacturing initiative to build drugs here, restore the nation’s…Super UserOctober 5, 2022
News NextCure Announces Initiation of Phase 1b/2 Clinical Trial to Evaluate NC410 in Combination with KEYTRUDA® (Pembrolizumab) in Patients with Immune Checkpoint Refractory or Naïve Solid Tumors BELTSVILLE, Md., Oct. 04, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed…Super UserOctober 5, 2022